Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review

被引:47
作者
Lovelace, Tiffany L.
Fox, Nyssa F.
Sood, Amit J.
Nguyen, Shaun A.
Day, Terry A.
机构
[1] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY | 2014年 / 117卷 / 05期
关键词
RADIATION-INDUCED XEROSTOMIA; QUALITY-OF-LIFE; ADENOVIRAL-MEDIATED TRANSFER; INCREASED FLUID SECRETION; PAROTID-GLAND FUNCTION; HUMAN AQUAPORIN-1 CDNA; POSTIRRADIATION XEROSTOMIA; DOUBLE-BLIND; FRACTIONATED RADIOTHERAPY; SUBMANDIBULAR-GLAND;
D O I
10.1016/j.oooo.2014.01.229
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective. To analyze the efficacy of various treatment options for radiation-induced hyposalivation in patients with head and neck cancer. Study Design. A literature review and meta-analysis was performed on all appropriate literature identified via MEDLINE/PubMed. Results. Fourteen articles were identified that met inclusion criteria for review, and 8 articles qualified for inclusion in the meta-analysis. The available literature addressed both objective and subjective responses of hyposalivation, xerostomia, or both to cholinergic agonists (such as pilocarpine and cevimeline), salivary substitutes, hyperbaric oxygen, and acupuncture. Conclusions. This analysis indicated that cholinergic agonists were more effective in treating radiation-induced hyposalivation compared with salivary substitutes, hyperbaric oxygen, and acupuncture. However, other treatment modalities, such as salivary substitutes and hyperbaric oxygen, were also found to subjectively improve patients' perception of xerostomia.
引用
收藏
页码:595 / 607
页数:13
相关论文
共 67 条
[1]  
Ang KK., 2002, Radiotherapy for Head and Neck Cancers: Indications and Techniques, V2nd
[2]   Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy [J].
Bardet, E ;
Martin, L ;
Calais, G ;
Tuchais, C ;
Bourhis, J ;
Rhein, B ;
Feham, N ;
Alphonsi, M .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :57-60
[3]  
Baum Bruce J, 2009, Handb Exp Pharmacol, P403, DOI 10.1007/978-3-540-79885-9_20
[4]   Development of a gene transfer-based treatment for radiation-induced salivary hypofunction [J].
Baum, Bruce J. ;
Zheng, Changyu ;
Alevizos, Ilias ;
Cotrim, Ana P. ;
Liu, Shuying ;
McCullagh, Linda ;
Goldsmith, Corinne M. ;
McDermott, Nancy ;
Chiorini, John A. ;
Nikolov, Nikolay P. ;
Illei, Gabor G. .
ORAL ONCOLOGY, 2010, 46 (01) :4-8
[5]  
Bennett MH, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004712.pub2, 10.1002/14651858.CD005005.pub2, 10.1002/14651858.CD004739.pub2, 10.1002/14651858.CD004954.pub2, 10.1002/14651858.CD004818.pub2]
[6]  
Blom M, 1996, ORAL ONCOL, V32B, P182
[7]  
Blom M, 2000, ORAL DIS, V6, P15
[8]   Phase III randomized trial of amifostine as a radioprotector in head and neck cancer [J].
Brizel, DM ;
Wasserman, TH ;
Henke, M ;
Strnad, V ;
Rudat, V ;
Monnier, A ;
Eschwege, F ;
Zhang, J ;
Russell, L ;
Oster, W ;
Sauer, R .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) :3339-3345
[9]   Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer [J].
Chambers, Mark S. ;
Posner, Marshall ;
Jones, Christopher Uwe ;
Biel, Merrill A. ;
Hodge, Kenneth M. ;
Vitti, Robert ;
Armstrong, Ingrid ;
Yen, Cindy ;
Weber, Randal S. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (04) :1102-1109
[10]  
Chitapanarux Imjai, 2008, Journal of the Medical Association of Thailand, V91, P1410